You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 211 No. 7, February 16, 1970 TABLE OF CONTENTS
  JAMA
  •  Online Features
  ARTICLES
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Evaluation of Therapeutic Efficacy of Amantadine in Patients With Naturally Occurring A2 Influenza

Yasushi Togo, MD; Richard B. Hornick, MD; Vincent J. Felitti, MD; Matthew L. Kaufman, MD; Albert T. Dawkins, Jr., MD; Vilis E. Kilpe, MD; James L. Claghorn, MD

JAMA. 1970;211(7):1149-1156.


Abstract

Amantadine hydrochloride had a chemotherapeutic effect in patients with naturally occurring Asian influenza during the epidemic of 1967 to 1968. In double-blind clinical trials in which 54 men were treated with amantadine and 48 men received placebo capsules, more rapid defervescence and improvement of some symptoms were achieved in the drug-treated patients. The effect was demonstrable when drug therapy was started approximately 20 hours after the patients became ill. The causative virus was recovered at a high rate during the first four days of therapy in both groups which indicated that the drug did not affect virus shedding. Systemic as well as local antibody titer increases which developed in amantadine-treated patients during convalescence were equivalent to those of the placebo-treated patients.



Author Affiliations

From the Division of Infectious Diseases, Department of Medicine, University of Maryland School of Medicine, Baltimore (Drs. Togo, Hornick, Felitti, Kaufman, Dawkins, and Kilpe), and Texas Research Institute of Mental Sciences, Houston (Dr. Claghorn).


Footnotes

Reprint requests to 29 S Greene St, Baltimore 21201 (Dr. Togo).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

The treatment of influenza with antiviral drugs
Stiver
CMAJ 2003;168:49-57.
ABSTRACT | FULL TEXT  

Efficacy and Safety of the Oral Neuraminidase Inhibitor Oseltamivir in Treating Acute Influenza: A Randomized Controlled Trial
Treanor et al.
JAMA 2000;283:1016-1024.
ABSTRACT | FULL TEXT  

Use of the Oral Neuraminidase Inhibitor Oseltamivir in Experimental Human Influenza: Randomized Controlled Trials for Prevention and Treatment
Hayden et al.
JAMA 1999;282:1240-1246.
ABSTRACT | FULL TEXT  

Antiviral chemotherapy and chemoprophylaxis
Dolin
Science 1985;227:1296-1303.
ABSTRACT  

Successful Treatment of Naturally Occurring Influenza A/USSR/77 H1N1
Van Voris et al.
JAMA 1981;245:1128-1131.
ABSTRACT  

Control of Influenza in the Hospital
HOFFMAN and DIXON
ANN INTERN MED 1977;87:725-728.
ABSTRACT  

Amantadine and Pulmonary Peripheral Airways
RUCKDESCHEL
ANN INTERN MED 1977;86:359-360.
ABSTRACT  

Amantadine Effect on Peripheral Airways Abnormalities in Influenza: A Study in 15 Students with Natural Influenza A Infection
LITTLE et al.
ANN INTERN MED 1976;85:177-182.
ABSTRACT  

Cyclooctylamine of Experimental in the Prevention Human Influenza
Togo et al.
JAMA 1972;220:837-841.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1970 American Medical Association. All Rights Reserved.